Novel Influenza A Surveillance Registry (H1N1)
Note that you will be prompted to log in or register an account
Accession Number
HLB00931212a
Study Type
Epidemiology Study
Collection Type
Open BioLINCC Study
See bottom of this webpage for request information
Study Period
October 2009 – October 2010
NHLBI Division
DLD
Dataset(s) Last Updated
January 3, 2018
Clinical Trial URLs
https://clinicaltrials.gov/ct2/show/NCT01046331
Primary Publication URLs
N/A
Consent
Commercial Use Data Restrictions No
Data Restrictions Based On Area Of Research No
Objectives
The purpose of this prospective surveillance registry was to characterize the demographics, clinical features, outcomes, and resource utilization of patients with H1N1 influenza infection who require intensive care.
Background
There are no pertinent animal studies of H1N1 influenza. Human studies are limited to case reports or case series which report on relatively limited number of patients. These reports suggest that although severe disease requiring critical care is rare among patients with H1N1 infection, the patients who do require ICU care have a rapidly progressive course with high disease severity. Unlike typical influenza, where the extremes of age (i.e. elderly and very young) and those with underlying cardiopulmonary comorbidities are at increased risk of developing severe and potentially fatal infections, young otherwise healthy patients (including children of all ages), obese patients, and pregnant females appear to be at an increased risk for severe disease from the novel influenza A (H1N1) virus.
Participants
The study data consists of 892 adult subjects and 838 pediatric subjects who were admitted to an intensive care unit at a participating site with confirmed or suspected Novel H1N1 Influenza infection. Subjects with influenza-like illness due to non-influenza disease and negative testing for influenza were excluded.
Design
Patients were enrolled on the day of ICU admission and baseline demographics collected from the medical record. The presenting clinical features and lab values for organ function were also collected. APACHE III (or PRISM for children) and Sepsis-related Organ Failure Assessment (SOFA) scores were calculated for data present in the medical record on enrollment. Crude outcomes were collected weekly in order to have a real-time picture of the clinical course. At ICU discharge, death or day 28, more in-depth outcomes were collected. 60-day followup was collected for patients who remained hospitalized beyond day 28. In children remaining hospitalized beyond day 60, this information was collected at day 90. Cause of death was requested.
Please note that researchers must be registered on this site to submit a request, and you will be prompted to log in. If you are not registered on this site, you can do so via the Request button. Registration is quick, easy and free.
Resources Available
Study Datasets OnlyStudy Documents
- Data Dictionary (PDF - 434.1 KB)
- Adult Forms (PDF - 636.4 KB)
- Pediatric Forms (PDF - 625.3 KB)
- Study Overview (PDF - 150.2 KB)
Persons using assistive technology may not be able to fully access information in the study documents. For assistance, Contact BioLINCC and include the web address and/or publication title in your message. If you need help accessing information in different file formats such as PDF, XLS, DOC, see Instructions for Downloading Viewers and Players.